Mangoceuticals, Inc. (MGRX)
Market Closed
26 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
0. 24
+0.01
+3.7532%
After Hours
$
+0.02 +6.6528% 0. 26
6.44M Market Cap
- P/E Ratio
- Div Yield
312,373 Volume
0 Eps
$ 0.23
Previous Close 
Want to track MGRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Why Is Mangoceuticals (MGRX) Stock Up 130% Today?
Mangoceuticals (NASDAQ: MGRX ) stock climbed up a staggering 130% at one point today after the company announced that its new oral formulations of its Semaglutide (“Slim”) and Tirzepatide (“Trim”) treatments have proven notably effective in clinical trials. What does this mean for MGRX stock?
Investorplace | 2 years ago
2026 © Marketlog. All Rights Reserved.
